Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Translume is a leading provider of glass microfluidic solutions and micro-optical components for the life sciences and analytical industries. The company leverages a proprietary femtosecond laser-assisted chemical etching process to manufacture high-precision, three-dimensional micro-channels and optical elements in fused silica. Their product portfolio includes flow cells, lab-on-a-chip devices, and integrated micro-systems used in applications such as flow cytometry, DNA sequencing, and chemical sensing. Translume serves as a critical partner for researchers and OEM manufacturers requiring robust, chemically inert, and optically transparent micro-scale platforms. Based in Ann Arbor, Michigan, the company provides both standard catalog items and custom engineering services to meet specific client requirements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Translume.